Viewing Study NCT03639935


Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2026-02-25 @ 9:39 PM
Study NCT ID: NCT03639935
Status: COMPLETED
Last Update Posted: 2025-06-03
First Post: 2018-08-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy
Sponsor: University of Michigan Rogel Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: UMCC 2018.044
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View